Description

Teicoplanin-Farmex (teicoplanin) lyophilisate for solution for injection 400 mg. vial №1 + solvent 3.2 ml

Ingredients

Teicoplanin lyophilisate for solution for injection 400 mg, solvent 3.2 ml.

Dosage

The recommended dosage of Teicoplanin-Farmex is determined by the severity of the infection. It is usually administered intravenously. Consult a healthcare professional for the correct dosage and administration.

Indications

Teicoplanin-Farmex is indicated for the treatment of serious infections caused by Gram-positive bacteria, including Staphylococcus aureus and Streptococcus pneumoniae.

Contraindications

Do not use Teicoplanin-Farmex if you are allergic to teicoplanin or any other ingredients in the product. It is important to inform your healthcare provider about any allergies before starting treatment.

Directions

Follow the instructions provided by your healthcare provider for the correct administration of Teicoplanin-Farmex. Do not self-administer this medication.

Scientific Evidence

Teicoplanin is a glycopeptide antibiotic with potent activity against various Gram-positive bacteria. Studies have shown its efficacy in treating infections such as endocarditis, septicemia, and bone and joint infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the effectiveness of teicoplanin in treating methicillin-resistant Staphylococcus aureus (MRSA) infections.

Additional Information

Teicoplanin-Farmex is well-tolerated by most patients, with common side effects including nausea, vomiting, and rash. It is important to complete the full course of treatment as prescribed by your healthcare provider to ensure the infection is fully eradicated.

Teicoplanin-Farmex works by inhibiting bacterial cell wall synthesis, leading to the death of the bacteria. It is considered a bactericidal antibiotic, meaning it kills bacteria rather than just inhibiting their growth. This mechanism of action makes it effective against a wide range of Gram-positive pathogens.

Clinical trials have shown that Teicoplanin-Farmex is comparable in efficacy to other glycopeptide antibiotics such as vancomycin. A study published in the European Journal of Clinical Microbiology & Infectious Diseases found no significant difference in clinical outcomes between teicoplanin and vancomycin in the treatment of serious Gram-positive infections.